Meeting ReportOncology, Basic and Translational - In vitro and In vivo Oncology
Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 containing nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention
Yang Luo, WenBin Jin, Li Yan, Yanran Huang, Haiyan Hong, Ran Wang, Jinping Qiao, Hank F. Kung and Lin Zhu
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241526;
Yang Luo
1Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, P. R. China
WenBin Jin
2Beijing Normal University
Li Yan
2Beijing Normal University
Yanran Huang
2Beijing Normal University
Haiyan Hong
3Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University)
Ran Wang
2Beijing Normal University
Jinping Qiao
2Beijing Normal University
Hank F. Kung
4University of Pennsylvania
Lin Zhu
2Beijing Normal University

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 containing nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention
Yang Luo, WenBin Jin, Li Yan, Yanran Huang, Haiyan Hong, Ran Wang, Jinping Qiao, Hank F. Kung, Lin Zhu
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241526;
Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 containing nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention
Yang Luo, WenBin Jin, Li Yan, Yanran Huang, Haiyan Hong, Ran Wang, Jinping Qiao, Hank F. Kung, Lin Zhu
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241526;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.